ArticleWorld journal of gastrointestinal surgery2026
Prediction of lymphovascular invasion in rectal cancer based on multimodal magnetic resonance imaging radiomics model.
Article in World journal of gastrointestinal surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLymphovascular invasion (LVI) is an independent prognostic factor in rectal cancer, but its assessment relies on postoperative pathology. Radiomics-based analysis of multimodal magnetic resonance imaging (MRI) can provide noninvasive preoperative prediction of LVI status, supporting precision treatment decisions.
aimTo construct a machine learning model based on multimodal MRI radiomics features for noninvasive preoperative prediction of LVI status in rectal cancer, providing decision support for individualized clinical treatment.
methodsA total of 278 patients with pathologically confirmed rectal cancer after surgery were retrospectively included and divided into training set (222 cases) and test set (56 cases) at an 8:2 ratio. Three sequences were used for scanning: Fat-suppressed T2-weighted imaging, diffusion-weighted imaging, and T1-weighted contrast-enhanced imaging. PyRadiomics software was used to extract radiomics features, which were then screened through stability assessment, variance filtering, correlation analysis, univariate screening, and least absolute shrinkage and selection operator regression for key features. Single-modal models, multimodal radiomics model, clinical model, and clinical-radiomics combined model were constructed respectively. Model performance was evaluated using receiver operating characteristic curves.
resultsAmong 278 patients, 121 (43.5%) were LVI-positive. Twenty-three key features were selected from initial 4200 features. Multivariate analysis showed that tumor diameter ≥ 4 cm, carcinoembryonic antigen ≥ 5 ng/mL, poor differentiation, T3-4 staging, N1-2 staging, and positive perineural invasion were independent predictors of LVI. In the test set, single-modal models achieved area under the curve (AUC) of 0.708-0.775, multimodal radiomics model achieved AUC of 0.835, clinical model achieved AUC of 0.782, and the combined model performed best (AUC = 0.867, sensitivity = 0.840, specificity = 0.806). Hosmer-Lemeshow test showed good calibration for all models (
conclusionMachine learning models based on multimodal MRI radiomics features can effectively predict LVI status in rectal cancer, with the combined model showing optimal performance, providing a valuable quantitative tool for preoperative clinical assessment and individualized treatment decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.